4.5 Review

Systematic review on the use of matrix-bound sealants in pancreatic resection

Journal

HPB
Volume 17, Issue 11, Pages 1033-1039

Publisher

ELSEVIER SCI LTD
DOI: 10.1111/hpb.12472

Keywords

-

Ask authors/readers for more resources

BackgroundPancreatic fistula is a potentially life-threatening complication after a pancreatic resection. The aim of this systematic review was to evaluate the role of matrix-bound sealants after a pancreatic resection interms of preventing or ameliorating the course of a post-operative pancreatic fistula. MethodsA systematic search was performed in the literature from May 2005 to April 2015. Included were clinical studies using matrix-bound sealants after a pancreatic resection, reporting a post-operative pancreatic fistula (POPF) according to the International Study Group on Pancreatic Fistula classification, in which grade B and C fistulae were considered clinically relevant. ResultsTwo were studies on patients undergoing pancreatoduodenectomy (sealants n=67, controls n=27) and four studies on a distal pancreatectomy (sealants n=258, controls n=178). After a pancreatoduodenectomy, 13% of patients treated with sealants versus 11% of patients without sealants developed a POPF (P=0.76), of which 4% versus 4% were clinically relevant (P=0.87). After a distal pancreatectomy, 42% of patients treated with sealants versus 52% of patients without sealants developed a POPF (P=0.03). Of these, 9% versus 12% were clinically relevant (P=0.19). ConclusionsThe present data do not support the routine use of matrix-bound sealants after a pancreatic resection, as there was no effect on clinically relevant POPF. Larger, well-designed studies are needed to determine the efficacy of sealants in preventing POPF after a pancreatoduodenectomy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Early Recurrence After Resection of Locally Advanced Pancreatic Cancer Following Induction Therapy An International Multicenter Study

Leonard W. F. Seelen, Anne Floortje van Oosten, Lilly J. H. Brada, Vincent P. Groot, Lois A. Daamen, Marieke S. Walma, Bastiaan F. van der Lek, Mike S. L. Liem, Gijs A. Patijn, Martijn W. J. Stommel, Ronald M. van Dam, Bas Groot Koerkamp, Olivier R. Busch, Ignace H. J. T. de Hingh, Casper H. J. van Eijck, Marc G. Besselink, Richard A. Burkhart, Inne H. M. Borel Rinkes, Christopher L. Wolfgang, Izaak Quintus Molenaar, Jin He, Hjalmar C. van Santvoort

Summary: The objective of this study was to establish a evidence-based cutoff and predictors for early recurrence in patients with resected locally advanced pancreatic cancer (LAPC). After analyzing long-term follow-up data, a cutoff time of 6 months was determined to differentiate between early and late recurrence, and early recurrence was associated with poor survival. Preoperative predictors included post-induction therapy carbohydrate antigen (CA) 19-9 level, tumor differentiation and postoperative predictors included poor tumor differentiation and lack of adjuvant chemotherapy. These findings are valuable for guiding and counseling patients with LAPC before and after resection.

ANNALS OF SURGERY (2023)

Article Surgery

Chyle Leak After Pancreatoduodenectomy Clinical Impact and Risk Factors in a Nationwide Analysis

Simone Augustinus, Anouk E. J. A. Latenstein, Bert R. Bonsing, Olivier Busch, Bas Groot Koerkamp, Ignace H. J. T. E. de Hingh, Vincent de Meijer, I. Quintus C. Molenaar, Hjalmar van Santvoort, Judith H. de Vos-Geelen, Casper G. van Eijck, Marc Besselink, Dutch Pancreatic Canc Grp

Summary: This study aimed to assess the clinical impact and risk factors of chyle leak (CL) after pancreatoduodenectomy. The nationwide Dutch Pancreatic Cancer Audit was used to include consecutive patients from all 19 centers. The rate of CL was 7.0% and it was associated with prolonged hospital stay. Vascular resection and open surgery were identified as predictors of CL.

ANNALS OF SURGERY (2023)

Article Surgery

Perforation and Fistula of the Gastrointestinal Tract in Patients With Necrotizing Pancreatitis A Nationwide Prospective Cohort

Hester M. Timmerhuis, Sven A. van Dijk, Robbert S. Hollemans, Devica J. Umans, Christina G. Sperna Weiland, Marc Besselink, Stefan A. W. J. Bouwense, Marco Bruno, Peter van Duijvendijk, Casper H. J. van Eijck, Yama Issa, J. Sven D. Mieog, I. Quintus Molenaar, Martijn W. J. L. Stommel, Thomas P. Bollen, Rogier C. Voermans, Robert C. Verdonk, Hjalmar van Santvoort, Dutch Pancreatitis Study Group

Summary: The aim of this study was to explore the incidence, risk factors, clinical course and treatment of gastrointestinal tract perforation and fistula in patients with necrotizing pancreatitis. The results showed that the incidence rate was 16%, with the stomach and duodenum being the most commonly affected sites. High C-reactive protein and early organ failure were identified as risk factors. Treatment varied depending on the affected site.

ANNALS OF SURGERY (2023)

Article Oncology

The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial

Jelle C. van Dongen, Eva Versteijne, Bert A. Bonsing, J. Sven D. Mieog, Ignace H. J. T. de Hingh, Sebastiaan Festen, Gijs A. Patijn, Ronald van Dam, Erwin van der Harst, Jan H. Wijsman, Koop Bosscha, Marion van der Kolk, Vincent E. de Meijer, Mike S. L. Liem, Olivier R. Busch, Marc G. H. Besselink, Geertjan van Tienhoven, Bas Groot Koerkamp, Casper H. J. van Eijck, Mustafa Suker

Summary: This study aimed to evaluate the value of staging laparoscopy in detecting occult metastases in patients with resectable or borderline resectable pancreatic cancer. The results showed that staging laparoscopy could detect occult metastases in about 10% of patients, and these patients were more likely to receive palliative systemic chemotherapy.
Article Gastroenterology & Hepatology

Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia

Nadine C. M. van Huijgevoort, Sanne A. M. Hoogenboom, Selma J. Lekkerkerker, Olivier R. Busch, Marco Del Chiaro, Paul Fockens, Inne Somers, Joanne Verheij, Rogier P. Voermans, Marc G. Besselink, Jeanin E. van Hooft

Summary: Background: Follow-up in patients with intraductal papillary mucinous neoplasm (IPMN) aims to detect advanced neoplasia (high-grade dysplasia/cancer) in an early stage. The 2015 American Gastroentero-logical Association (AGA), 2017 International Association of Pancreatology (IAP), and the 2018 European Study Group on Cystic tumours of the Pancreas (European) guidelines differ in their recommendations on indications for surgery. However, it remains unclear which guideline is most accurate in predicting advanced neoplasia in IPMN. Methods: Patients who underwent surgery were extracted from a prospective database (January 2006-January 2021). In patients with IPMN, final pathology was compared with the indication for surgery according to the guidelines. ROC-curves were calculated to determine the diagnostic accuracy for each guideline. Results: Overall, 247 patients underwent surgery for cystic lesions. In 145 patients with IPMN, 52 had advanced neoplasia, of which the AGA guideline would have advised surgery in 14 (27%), the IAP and European guideline in 49 (94%) and 50 (96%). In 93 patients without advanced neoplasia, the AGA, IAP, and European guidelines would incorrectly have advised surgery in 8 (8.6%), 77 (83%) and 71 (76%). Conclusion: The European and IAP guidelines are clearly superior in detecting advanced neoplasia in IPMN as compared to the AGA, albeit at the cost of a higher rate of unnecessary surgery. To harmonize care and to avoid confusion caused by conflicting statements, a global evidence-based guideline for PCN in collaboration with the various guidelines groups is required once the current guidelines require an update. (c) 2023 Published by Elsevier B.V. on behalf of IAP and EPC.

PANCREATOLOGY (2023)

Article Oncology

Intraoperative Ultrasound During Surgical Exploration in Patients with Pancreatic Cancer and Vascular Involvement (ULTRAPANC): A Prospective Multicenter Study

Nynke Michiels, Deesje Doppenberg, Jesse V. Groen, Eran van Veldhuisen, Bert A. Bonsing, Olivier R. Busch, A. Stijn L. P. Crobach, Otto M. van Delden, Susan van Dieren, Arantza Farina, Ignace H. J. T. de Hingh, Rob Hurks, Joost Nederend, Shirin Shahbazi Feshtali, Yeliz Tank, A. L. Vahrmeijer, Martin Wasser, Marc G. Besselink, J. Sven D. Mieog

Summary: Intraoperative ultrasound (IOUS) can provide real-time additional information during surgery for pancreatic cancer with vascular involvement, and it has been found to change the resectability status in over one-third of patients, facilitating progress during surgical exploration. This finding should be confirmed by larger studies.

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer

Simone Augustinus, Pascale J. M. V. Schafrat, Boris A. Janssen, Bert Bonsing, Lodewijk A. A. R. Brosens, Olivier Busch, Stijn Crobach, Michail H. Doukas, Casper van Eijck, Lydia G. M. van der Geest, Bas Groot Koerkamp, Ignace H. J. T. de Hingh, G. Mihaela C. Raicu, Hjalmar van Santvoort, Marie-Louise van Velthuysen, Joanne G. Verheij, Marc Besselink, Arantza Farina Sarasqueta

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer-An International Retrospective Cohort Study

Jeffrey W. Chen, Tess M. E. van Ramshorst, Sanne Lof, Bilal Al-Sarireh, Bergthor Bjornsson, Ugo Boggi, Fernando Burdio, Giovanni Butturini, Riccardo Casadei, Andrea Coratti, Mathieu D'Hondt, Safi Dokmak, Bjorn Edwin, Alessandro Esposito, Jean M. Fabre, Giovanni Ferrari, Fadhel S. Fteriche, Giuseppe K. Fusai, Bas Groot Koerkamp, Thilo Hackert, Asif Jah, Jin-Young Jang, Emanuele F. Kauffmann, Tobias Keck, Alberto Manzoni, Marco Marino, Quintus Molenaar, Elizabeth Pando Rau, Patrick Pessaux, Andrea Pietrabissa, Zahir Soonawalla, Robert P. Sutcliffe, Lea Timmermann, Steven White, Vincent S. Yip, Alessandro Zerbi, Mohammad Abu Hilal, Marc G. Besselink

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Surgery

Nationwide validation of the ISGPS risk classification for postoperative pancreatic fistula after pancreatoduodenectomy: ?Less is more?

J. Annelie Suurmeijer, Anouk M. Emmen, Bert A. Bonsing, Olivier R. Busch, Freek Daams, Casper H. van Eijck, Susan van Dieren, Ignace H. de Hingh, Tara M. Mackay, J. Sven Mieog, I. Quintus Molenaar, Martijn W. Stommel, Vincent E. de Meijer, Hjalmar C. van Santvoort, Bas Groot Koerkamp, Marc G. Besselink, Dutch Pancreat Canc Grp

Summary: This study aimed to validate the International Study Group of Pancreatic Surgery risk classification for postoperative pancreatic fistula after pancreatoduodenectomy. The study found that a simplified 3-tier classification system can achieve similar predictive value compared to the original 4-tier classification system.

SURGERY (2023)

Review Medicine, General & Internal

Computer-Aided Detection for Pancreatic Cancer Diagnosis: Radiological Challenges and Future Directions

Mark Ramaekers, Christiaan G. A. Viviers, Boris V. Janssen, Terese A. E. Hellstrom, Lotte Ewals, Kasper van der Wulp, Joost Nederend, Igor Jacobs, Jon R. Pluyter, Dimitrios Mavroeidis, Fons van der Sommen, Marc G. Besselink, Misha D. P. Luyer, EMTIC Oncology Collaborative Grp

Summary: Radiological imaging is crucial for detecting and treating pancreatic ductal adenocarcinoma (PDAC), but there are challenges in using these techniques in daily clinical practice. AI-based computer-aided detection (CAD) has shown promise in improving the radiological detection of cancer, but widespread adoption in clinical practice has not yet occurred.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Oncology

Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis

Simone Augustinus, Gajanan Thurairajah, Marc G. Besselink, Hanneke W. M. van Laarhoven, Martijn G. H. van Oijen, Tara M. Mackay, Johanna W. Wilmink

Summary: Due to increased use of imaging, more advanced stages of cancer are being diagnosed in an early, asymptomatic phase. The optimal timing of chemotherapy in asymptomatic patients with advanced cancer is still uncertain, and there is a lack of systematic reviews on this topic.

ONCOLOGIST (2023)

Article Surgery

Learning Curves of Minimally Invasive Distal Pancreatectomy in Experienced Pancreatic Centers

Sanne Lof, Linda Claassen, Gerjon Hannink, Bilal Al-Sarireh, Bergthor Bjornsson, Ugo Boggi, Fernando Burdio, Giovanni Butturini, Giovanni Capretti, Riccardo Casadei, Safi Dokmak, Bjorn Edwin, Alessandro Esposito, Jean M. Fabre, Giovanni Ferrari, Asmund A. Fretland, Fadhel S. Fteriche, Giuseppe K. Fusai, Alessandro Giardino, Bas Groot Koerkamp, Mathieu D'Hondt, Asif Jah, Sivesh K. Kamarajah, Emanuele F. Kauffmann, Tobias Keck, Stijn van Laarhoven, Alberto Manzoni, Marco V. Marino, Ravi Marudanayagam, Izaak Q. Molenaar, Patrick Pessaux, Edoardo Rosso, Roberto Salvia, Zahir Soonawalla, Regis Souche, Steven White, Frans van Workum, Alessandro Zerbi, Camiel Rosman, Martijn W. J. Stommel, Mohammed Abu Hilal, Marc G. Besselink

Summary: Understanding the learning curve of MIDP is important in reducing patient harm. This multicenter study analyzed data from 26 European centers to evaluate the length of the learning curve. The findings suggest that 85 procedures are needed to achieve optimal outcomes, while earlier mastery can be achieved for conversion rate, operation time, and intraoperative blood loss.

JAMA SURGERY (2023)

Article Surgery

Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials

Deesje Doppenberg, Jacob L. van Dam, Youngmin Han, Bert A. Bonsing, Olivier R. Busch, Sebastiaan Festen, Erwin van der Harst, Ignace H. de Hingh, Marjolein Y. Homs, Wooil Kwon, Mirang Lee, Daan J. Lips, Vincent E. de Meijer, I. Quintus Molenaar, Joost J. Nuyttens, Gijs A. Patijn, Stijn van Roessel, George P. van der Schelling, Mustafa Suker, Eva Versteijne, Judith de Vos-Geelen, Johanna W. Wilmink, Casper H. J. van Eijck, Geertjan van Tienhoven, Jin-Young Jang, Marc G. Besselink, Bas Groot Koerkamp

Summary: Two randomized controlled trials (RCTs) have shown that neoadjuvant chemoradiotherapy (CRT) is associated with better survival in patients with resectable and borderline resectable pancreatic cancers compared to upfront surgery. The baseline serum CA19-9 level does not affect the treatment effect of neoadjuvant CRT, indicating that it should not be withheld based on CA19-9 concentration.

BRITISH JOURNAL OF SURGERY (2023)

Review Surgery

Two decades of surgical randomized controlled trials: worldwide trends in volume and methodological quality

Aagje J. M. Pronk, Anne Roelofs, David R. Flum, H. Jaap Bonjer, Mohammed Abu Hilal, Marcel G. W. Dijkgraaf, Marc G. Besselink, Usama Ahmed Ali

Summary: This systematic review analyzed 1188 surgical randomized controlled trials (RCTs) from three different years (1999, 2009, and 2019) and found that the global volume of published surgical RCTs remained stable in the past decade, but the proportion of RCTs with low risk of bias increased from 14.7% to 22.1%. Asia saw an increase in surgical RCTs, while Europe saw a decrease.

BRITISH JOURNAL OF SURGERY (2023)

Correction Surgery

Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study (vol 109,pg 1150, 2022)

J. Annelie Suurmeijer, Eline C. Soer, Mark P. G. Dings, Yongsoo Kim, Marin Strijker, Bert A. Bonsing, Lodewijk A. A. Brosens, Olivier R. Busch, Jesse Groen, Johannes B. Halfwerk, Robbert A. E. Slooff, Hanneke W. M. van Laarhoven, I. Quintus Molenaar, G. Johan A. Offerhaus, Hans Morreau, Marc J. van de Vijver, Arantza Farina Sarasqueta, Joanne Verheij, Marc G. Besselink, Maarten F. Bijlsma, Frederike Dijk

BRITISH JOURNAL OF SURGERY (2023)

No Data Available